Castell Morley, A. (2021). Predictive factors in HER2-positive early breast cancer: Endogenous HER2-specific immune response as an early predictive marker for pathologic complete response and disease-free survival.
Chicago Style (17th ed.) CitationCastell Morley, Alexandra. Predictive Factors in HER2-positive Early Breast Cancer: Endogenous HER2-specific Immune Response as an Early Predictive Marker for Pathologic Complete Response and Disease-free Survival. Heidelberg, 2021.
MLA (9th ed.) CitationCastell Morley, Alexandra. Predictive Factors in HER2-positive Early Breast Cancer: Endogenous HER2-specific Immune Response as an Early Predictive Marker for Pathologic Complete Response and Disease-free Survival. 2021.
Warning: These citations may not always be 100% accurate.